サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1147574

患者マッチングAI臨床試験ソリューションの市場規模、シェアと動向分析レポート：治療用途別、最終用途別、地域別、セグメント別予測、2022年～2030年

AI-based Clinical Trial Solutions For Patient Matching Market Size, Share & Trends Analysis Report By Therapeutic Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.94円
患者マッチングAI臨床試験ソリューションの市場規模、シェアと動向分析レポート：治療用途別、最終用途別、地域別、セグメント別予測、2022年～2030年
出版日: 2022年10月03日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

患者マッチングAI臨床試験ソリューションの市場成長・動向

Grand View Research, Inc.の最新レポートによると、患者マッチングAI臨床試験ソリューションの世界市場規模は、予測期間中に26.7%の複合年間成長率（CAGR）を記録し、2030年までに19億米ドルに達すると予測されているとのことです。業界成長の主な要因は、慢性疾患の世界の発生率の増加、ヘルスケア分野の拡大への投資の増加、新技術の導入などです。

また、臨床試験の実施における人工知能（AI）ベースの技術の採用の増加や、この分野におけるスタートアップ企業の増加も、市場に新たな機会をもたらしています。例えば、2022年2月、Qureightはシード資金調達において、臨床試験プロセスのタイムラインを短縮し、さらに医薬品開発のコスト削減に貢献するAIベースのプラットフォームで150万米ドルを調達しました。主要なバイオ製薬大手は、より良い患者管理と臨床試験結果のために高度な技術的ソリューションを導入しています。

これらのプラットフォームは、臨床試験のサイクルタイムとコストをさらに削減し、臨床試験開発の生産性と精度を向上させます。AIベースのソリューションには自然言語処理（NLP）アルゴリズムが組み込まれており、臨床試験と患者登録の一致率を高めることができます。例えば、患者マッチングAI臨床試験ソリューションは、肺がん試験研究における患者の募集を58.4％増加させた。このような利点は、市場の成長をさらに後押ししています。

治療用途に基づくと、世界中でがんの有病率が上昇していること、がんの治療ソリューションを開発するイニシアチブが高まっていることから、2021年には腫瘍学が最大の市場シェア23.2%を占めています。しかし、心臓発作や脳卒中などの症例が増加していることから、予測期間中は心臓血管疾患分野が最も速い成長率を示すと予想されます。

エンドユーザー別では、製薬企業が66.0%と最も高い収益シェアを占めています。これは、製薬企業の主なプレーヤーが、新薬ターゲットを特定するためにAIベースの技術を使用してバイオマーカーと診断のより良い開発に注力し、薬の開発と臨床試験のプロセスを簡素化していることに起因します。

地域別では、2021年に北米が43.8%の最大市場シェアを占めました。しかし、アジア太平洋は、AIベースの臨床技術の浸透が進み、AIを採用するための政府の取り組みが支持されていることから、予測期間中に最も速い成長率を示すと予想されます。

患者マッチングのためのAIベースの臨床試験ソリューション市場のレポートハイライト

慢性疾患の有病率の増加や臨床試験プロセスにおけるAIベース技術の採用拡大により、2021年の患者マッチングAI臨床試験ソリューションの世界市場規模は2億3060万米ドルと評価された

2021年、治療用途に基づくと、オンコロジーが23.2%と最も高い収益シェアを占めました。世界中でがんの普及率が高まっていることが臨床試験数の増加につながっており、市場にプラスの影響を与えている

2021年、製薬企業は最終用途に基づき66.0%の最高収益シェアを占めました。この成長は、臨床試験におけるAIベースのソリューションの利用が増加していることに起因している

2021年の患者マッチングAI臨床試験ソリューションは、主要プレイヤーの存在、生活習慣病の増加、高齢者人口の増加、ヘルスケア分野の進歩の拡大により、北米が全体の43.8%のシェアを占めた

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 市場の定義
  • 調査手法
    • 情報調達
      • 購入したデータベース
      • GVRの内部データベース
    • 1次調査
  • 調査範囲と前提
  • データソースのリスト

第2章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し

第3章 世界の患者マッチングAI臨床試験ソリューション市場の変数、動向、および範囲

  • 浸透と成長の見通しのマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 患者マッチングAI臨床試験ソリューション市場分析ツール
    • 業界分析- ポーターズ
      • サプライヤーの交渉力
      • 買い手の交渉力
      • 代替の脅威
      • 新規参入者からの脅威
      • 競争企業間の敵対関係
  • PESTEL分析
    • 政治情勢
    • 経済・社会情勢
    • テクノロジー情勢
    • 法的情勢
    • テクノロジー情勢
  • 主要取引と戦略的提携分析
  • COVID-19市場への影響

第4章 患者マッチングAI臨床試験ソリューション市場：治療アプリケーションの推定・動向分析

  • 定義と範囲
  • 世界の患者マッチングAI臨床試験ソリューション：治療アプリケーション市場シェア分析、2021年および2030年
  • 腫瘍学
  • 心血管疾患
  • 神経疾患または状態
  • 代謝疾患
  • 感染症
  • その他

第5章 患者マッチングAI臨床試験ソリューション市場：最終用途の推定・動向分析

  • 定義と範囲
  • 世界の患者マッチングAI臨床試験ソリューション：最終用途市場シェア分析、2020年および2030年
  • 製薬会社
  • アカデミア
  • その他

第6章 患者マッチングAI臨床試験ソリューション市場：地域の推定・動向分析、治療用途と最終用途別

  • 世界の患者マッチングAI臨床試験ソリューション：地域変動分析
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • ロシア
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • MEA
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第7章 企業プロファイル

  • Unlearn.AI, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Antidote Technologies, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Deep6.ai
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Mendel.ai
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Aris Global
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Deep Lens AI
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • AmeriSourceBergen Corporation
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Koneksa
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Microsoft Corporation
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • GNS Healthcare
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
図表

List of Tables

  • TABLE 1 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 2 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 3 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 4 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 5 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 6 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 7 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 8 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 9 U.K. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 10 U.K. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 11 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 12 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 13 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 14 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 15 France AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 16 France AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 17 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 18 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 19 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 20 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 21 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 22 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 23 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 24 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 25 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 26 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 27 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 28 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 29 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 30 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 31 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 32 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 33 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 34 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 35 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 36 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 37 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 38 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 39 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 40 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 41 Middle East & Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 42 Middle East & Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 43 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 44 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 45 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 46 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 47 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 48 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 AI-based Clinical Trial Solutions for Patient Matching market snapshot, 2021 (USD Million)
  • FIG. 6 AI-based Clinical Trial Solutions for Patient Matching market trends & outlook
  • FIG. 7 Penetration & growth prospect mapping
  • FIG. 8 Market driver analysis (Current & future impact)
  • FIG. 9 Market restraint analysis (Current & future impact)
  • FIG. 10 AI-based Clinical Trial Solutions for Patient Matching market, therapeutic application outlook key takeaways (USD Million)
  • FIG. 11 AI-based Clinical Trial Solutions for Patient Matching market: therapeutic application movement analysis (USD Million), 2020 & 2030
  • FIG. 12 Oncology Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 13 Cardiovascular diseases Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 14 Neurological Diseases or Conditions Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 15 Metabolic Diseases Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 16 Infectious Diseases Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 17 Other Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 18 AI-based Clinical Trial Solutions for Patient Matching market, end-use outlook key takeaways (USD Million)
  • FIG. 19 AI-based Clinical Trial Solutions for Patient Matching market: end-use movement analysis (USD Million), 2020 & 2030
  • FIG. 20 Pharmaceutical companies Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 21 Academia Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 22 Others Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 23 AI-based Clinical Trial Solutions for Patient Matching market, regional outlook key takeaways (USD Million)
  • FIG. 24 AI-based Clinical Trial Solutions for Patient Matching market: Regional movement analysis (USD Million), 2020 & 2030
  • FIG. 25 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 26 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 27 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 28 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 29 U.K AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 30 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 31 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 32 France-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 33 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 34 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 35 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 36 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 37 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 38 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 39 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 40 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 41 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 42 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 43 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 44 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 45 MEA AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 46 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 47 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 48 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
目次
Product Code: GVR-4-68039-982-8

AI-based Clinical Trial Solutions For Patient Matching Market Growth & Trends:

The global AI-based clinical trial solutions for patient matching market size is expected to reach USD 1.9 billion by 2030, registering a compound annual growth rate (CAGR) of 26.7% during the forecast period, according to a new report by Grand View Research, Inc. The major factors attributing the industry growth are the increasing worldwide incidences of chronic diseases, rising investment in the expansion of the healthcare sector, and the introduction of new technologies.

The rising adoption of artificial intelligence(AI)-based technologies for conducting clinical trials and the increasing number of start-ups in this field are also opening new opportunities for the market. For instance, in February 2022, in their seed funding, Qureight raised USD 1.50 million for their AI-based platform which reduces the timeline for the clinical trials process and further helps in reducing the cost of medicine development. Major bio-pharma giants are implementing advanced technological solutions for better patient management and clinical trial results.

These platforms further reduce clinical trial cycle time & cost, thereby increasing productivity & accuracy of the trial development. AI-based solutions incorporate natural language processing (NLP) algorithms which enhances the match rate between clinical trials and patient enrollment. For instance, AI-enabled clinical trial solutions used in matching patients have increased patient recruitment in lung cancer trial studies by 58.4%. Such advantages are further driving the market growth.

Based on therapeutic application, oncology held the largest market share 23.2% in 2021 owing to the rise in the prevalence of cancer all over the globe and rising initiatives to develop therapeutic solutions for oncology. However, the cardiovascular disease segment is expected to show the fastest growth rate during the forecast period owing to increasing cases of heart attack, stroke, and others.

Based on end users, pharmaceutical companies accounted for the highest revenue share of 66.0% owing to the growing focus on better development of bio-markers and diagnostics using AI-based technologies to identify the new medicine target and simplify the process of development of medicine and clinical trials by key players of pharmaceutical companies.

Based on the region North America held the largest market share of 43.8% in 2021. However, Asia Pacific is expected to show the fastest growth rate during the forecast period due to the increasing penetration of AI-based clinical technologies and supportive government initiatives for adopting AI.

AI-based Clinical Trial Solutions For Patient Matching Market Report Highlights:

  • The global AI-based clinical trial solutions for patient matching market size was valued at USD 230.6 million in 2021, owing to the increasing prevalence of chronic diseases and growing adoption of AI-based technologies in the clinical trial process
  • In 2021, based on therapeutic applications, oncology accounted for the highest revenue share of 23.2%. The growing penetration rate of cancer throughout the world is leading to an increase in the number of clinical trials and thus, impacting the market positively
  • In 2021, pharmaceutical companies accounted for the highest revenue share of 66.0% based on end-use. The growth is attributed to the rising usage of AI-based solutions for clinical trials
  • North America dominated the AI-based clinical trial solution for patient matching with 43.8% of the total share in 2021, owing to the presence of key players, increasing prevalence of lifestyle disorders, growing elderly population, and growing advancement in the healthcare sector

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Market Definition
  • 1.3 Research Methodology
    • 1.3.1 Information Procurement
      • 1.3.1.1 Purchased database
      • 1.3.1.2 GVR's internal database
    • 1.3.2 Primary Research
  • 1.4 Research Scope and Assumptions
  • 1.5 List of Data Sources

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook

Chapter 3 Global AI-based Clinical Trial Solutions for Patient Matching Market Variables, Trends, & Scope

  • 3.1 Penetration and Growth Prospect Mapping
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
  • 3.3 Global AI-based Clinical Trial Solutions for Patient Matching Market Analysis Tools
    • 3.3.1 Industry Analysis - Porter's
      • 3.3.1.1 Bargaining power of the suppliers
      • 3.3.1.2 Bargaining power of the buyers
      • 3.3.1.3 Threats of substitution
      • 3.3.1.4 Threats from new entrants
      • 3.3.1.5 Competitive rivalry
  • 3.4. PESTEL Analysis
    • 3.4.1 Political landscape
    • 3.4.2 Economic and Social landscape
    • 3.4.3 Technology landscape
    • 3.4.4 Legal landscape
    • 3.4.5 Technology landscape
  • 3.5. Major Deals & Strategic Alliances Analysis
  • 3.6 COVID-19 Impact on the market

Chapter 4 AI-based Clinical Trial Solutions for Patient Matching Market: Therapeutic Application Estimates & Trend Analysis

  • 4.1 Definitions & Scope
  • 4.2 Global AI-based Clinical Trial Solutions for Patient Matching Market: Therapeutic Application Market Share Analysis, 2021 and 2030
  • 4.3 Oncology
    • 4.3.1 Oncology analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 4.4 Cardiovascular Diseases
    • 4.4.1 Cardiovascular Diseases Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 4.5 Neurological Diseases or Conditions
    • 4.5.1 Neurological Diseases or Conditions Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 4.6 Metabolic Diseases
    • 4.6.1 Metabolic Diseases Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 4.7 Infectious Diseases
    • 4.7.1 Infectious Diseases Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 4.8 Others
    • 4.8.1 Others analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)

Chapter 5 AI-based Clinical Trial Solutions for Patient Matching Market: End-Use Estimates & Trend Analysis

  • 5.1 Definitions & Scope
  • 5.2 Global AI-based Clinical Trial Solutions for Patient Matching Market: End-Use Market Share Analysis, 2020 and 2030
  • 5.3 Pharmaceutical Companies
    • 5.3.1 Pharmaceutical Companies Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 5.4 Academia
    • 5.4.1 Academia analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 5.5 Others
    • 5.5.1 Others analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)

Chapter 6 AI-based Clinical Trial Solutions for Patient Matching Market: Regional Estimates & Trend Analysis, By Therapeutic Application & End-Use

  • 6.1 Global AI-based Clinical Trial Solutions for Patient Matching Market: Regional Movement Analysis
  • 6.2 North America
    • 6.2.1 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts ByTherapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.2.2 U.S.
      • 6.2.2.1 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.2 U.K.
      • 6.3.2.1 U.K. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts by Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.4 Spain
      • 6.3.4.1 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.5 France
      • 6.3.5.1 France AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.6 Italy
      • 6.3.6.1 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.7 Russia
      • 6.3.7.1 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.4.2 China
      • 6.4.2.1 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.4.3 Japan
      • 6.4.3.1 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.4.4 India
      • 6.4.4.1 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.4.5 South Korea
      • 6.4.5.1 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.4.6 Australia
      • 6.4.6.1 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.5.4 Argentina
      • 6.5.4.1 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
  • 6.6 MEA
    • 6.6.1 MEA AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.6.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.6.4 UAE
      • 6.6.4.1 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Unlearn.AI, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Performance
    • 7.1.3 Product Benchmarking
    • 7.1.4 Strategic Initiatives
  • 7.2 Antidote Technologies, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Performance
    • 7.2.3 Product Benchmarking
    • 7.2.4 Strategic Initiatives
  • 7.3 Deep6.ai
    • 7.3.1 Company Overview
    • 7.3.2 Financial Performance
    • 7.3.3 Product Benchmarking
    • 7.3.4 Strategic Initiatives
  • 7.4 Mendel.ai
    • 7.4.1 Company Overview
    • 7.4.2 Financial Performance
    • 7.4.3 Product Benchmarking
    • 7.4.4 Strategic Initiatives
  • 7.5 Aris Global
    • 7.5.1 Company Overview
    • 7.5.2 Financial Performance
    • 7.5.3 Product Benchmarking
    • 7.5.4 Strategic Initiatives
  • 7.6 Deep Lens AI
    • 7.6.1 Company Overview
    • 7.6.2 Financial Performance
    • 7.6.3 Product Benchmarking
    • 7.6.4 Strategic Initiatives
  • 7.7 AmeriSourceBergen Corporation
    • 7.7.1 Company Overview
    • 7.7.2 Financial Performance
    • 7.7.3 Product Benchmarking
    • 7.7.4 Strategic Initiatives
  • 7.8 Koneksa
    • 7.8.1 Company Overview
    • 7.8.2 Financial Performance
    • 7.8.3 Product Benchmarking
    • 7.8.4 Strategic Initiatives
  • 7.9 Microsoft Corporation
    • 7.9.1 Company Overview
    • 7.9.2 Financial Performance
    • 7.9.3 Product Benchmarking
    • 7.9.4 Strategic Initiatives
  • 7.10 GNS Healthcare
    • 7.10.1 Company Overview
    • 7.10.2 Financial Performance
    • 7.10.3 Product Benchmarking
    • 7.10.4 Strategic Initiatives